AARD (AARD) reported EBIT of -$22.46M in Q1 2026.

How has AARD's EBIT changed year-over-year?

AARD's EBIT decreased by 114.6% year-over-year, from -$10.47M to -$22.46M.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

AARD AARD EBIT

EBIT at other companies

Relmada Therapeutics, Inc.RLMD

-$19.46M-6.8%

Rhythm Pharmaceuticals, Inc.RYTM

-$52.36M-11.4%

Aquestive Therapeutics, Inc.AQST

-$4.2M+78.3%

Viking TherapeuticsVKTX

-$164.13M-196%

ArvinasARVN

-$63.8M-189%

AbbVieABBV

——

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

−$22.5Moperating income=-$22.46M

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's EBIT?: AARD (AARD) reported EBIT of -$22.46M in Q1 2026.
How has AARD's EBIT changed year-over-year?: AARD's EBIT decreased by 114.6% year-over-year, from -$10.47M to -$22.46M.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.